Trial
NCT04108481
Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Iowa
Collaborators
Biocompatibles UK Ltd; AstraZeneca
Condition
Colorectal Cancer Metastatic
Intervention
Durvalumab
Why stopped
DSMC-directed closure
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-03-28